Neuroplastin 65 deficiency reduces amyloid plaque formation and cognitive deficits in an Alzheimer's disease mouse model

被引:0
|
作者
Wu, Dan-Dan [1 ]
Cheng, Jie [1 ]
Zheng, Ya-Ni [1 ]
Liu, Yu-Tong [2 ]
Hou, Shuang-Xin [3 ]
Liu, Li-Fen [1 ]
Huang, Liang [1 ,4 ]
Yuan, Qiong-Lan [1 ,4 ]
机构
[1] Tongji Univ, Shanghai Tongji Hosp, Dept Neurol, Sch Med, Shanghai, Peoples R China
[2] Univ Nebraska Med Ctr, Dept Radiol, Omaha, NE USA
[3] Fudan Univ, Shanghai Pudong Hosp, Dept Neurobiol, Shanghai, Peoples R China
[4] Tongji Univ, Dept Human Anat Histol & Embryol, Sch Med, Shanghai, Peoples R China
基金
中国国家自然科学基金; 上海市自然科学基金;
关键词
neuroplastin; 65; Alzheimer's disease; amyloid plaques; neuroinflammation; 5-hydroxytryptamine receptor 3A subunit; glial activation; SYNAPTIC GLYCOPROTEIN NEUROPLASTIN; ADHESION MOLECULE NEUROPLASTIN-65; LONG-TERM POTENTIATION; RECEPTOR; BETA; EXPRESSION; DEPOSITION; GP65; GP55;
D O I
10.3389/fncel.2023.1129773
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
IntroductionAlzheimer's disease (AD) is characterized by increasing cognitive dysfunction, progressive cerebral amyloid beta (A beta) deposition, and neurofibrillary tangle aggregation. However, the molecular mechanisms of AD pathologies have not been completely understood. As synaptic glycoprotein neuroplastin 65 (NP65) is related with synaptic plasticity and complex molecular events underlying learning and memory, we hypothesized that NP65 would be involved in cognitive dysfunction and A beta plaque formation of AD. For this purpose, we examined the role of NP65 in the transgenic amyloid precursor protein (APP)/presenilin 1 (PS1) mouse model of AD. MethodsNeuroplastin 65-knockout (NP65(-/-)) mice crossed with APP/PS1 mice to get the NP65-deficient APP/PS1 mice. In the present study, a separate cohort of NP65-deficient APP/PS1 mice were used. First, the cognitive behaviors of NP65-deficient APP/PS1 mice were assessed. Then, A beta plaque burden and A beta levels in NP65-deficient APP/PS1 mice were measured by immunostaining and western blot as well as ELISA. Thirdly, immunostaining and western blot were used to evaluate the glial response and neuroinflammation. Finally, protein levels of 5-hydroxytryptamin (serotonin) receptor 3A and synaptic proteins and neurons were measured. ResultsWe found that loss of NP65 alleviated the cognitive deficits of APP/PS1 mice. In addition, A beta plaque burden and A beta levels were significantly reduced in NP65-deficient APP/PS1 mice compared with control animals. NP65-loss in APP/PS1 mice resulted in a decrease in glial activation and the levels of pro- and anti-inflammatory cytokines (IL-1 beta, TNF-alpha, and IL-4) as well as protective matrix YM-1 and Arg-1, but had no effect on microglial phenotype. Moreover, NP65 deficiency significantly reversed the increase in 5-hydroxytryptamine (serotonin) receptor 3A (Htr3A) expression levels in the hippocampus of APP/PS1 mice. DiscussionThese findings identify a previously unrecognized role of NP65 in cognitive deficits and A beta formation of APP/PS1 mice, and suggest that NP65 may serve as a potential therapeutic target for AD.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer's disease
    Ballesteros-Alvarez, Josue
    Nguyen, Wynnie
    Sivapatham, Renuka
    Rane, Anand
    Andersen, Julie K. K.
    [J]. GEROSCIENCE, 2023, 45 (02) : 1095 - 1113
  • [2] Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer’s disease
    Josué Ballesteros-Álvarez
    Wynnie Nguyen
    Renuka Sivapatham
    Anand Rane
    Julie K. Andersen
    [J]. GeroScience, 2023, 45 : 1095 - 1113
  • [3] Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
    Spilman, Patricia
    Podlutskaya, Natalia
    Hart, Matthew J.
    Debnath, Jayanta
    Gorostiza, Olivia
    Bredesen, Dale
    Richardson, Arlan
    Strong, Randy
    Galvan, Veronica
    [J]. PLOS ONE, 2010, 5 (03):
  • [4] Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease
    Wei, Chao
    Zhang, Wei
    Zhou, Qiong
    Zhao, Chao
    Du, Ying
    Yan, Qi
    Li, Zhuyi
    Miao, Jianting
    [J]. NEUROCHEMICAL RESEARCH, 2016, 41 (08) : 1924 - 1938
  • [5] Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer’s Disease
    Chao Wei
    Wei Zhang
    Qiong Zhou
    Chao Zhao
    Ying Du
    Qi Yan
    Zhuyi Li
    Jianting Miao
    [J]. Neurochemical Research, 2016, 41 : 1924 - 1938
  • [6] Sargassum fusiforme improves memory and reduces amyloid plaque pathology in an Alzheimer's disease mouse model
    Bogie, J.
    Hoeks, C.
    Schepers, M.
    Tiane, A.
    Cuypers, A.
    Leijten, F.
    Chintapakorn, Y.
    Suttyut, T.
    Pornpakakul, S.
    Struik, D.
    Kerksiek, A.
    Liu, H.
    Hellings, N.
    Martinez-Marinez, P.
    Jonker, J.
    Dewachter, I.
    Sijbrands, E.
    Walter, J.
    Hendriks, J.
    Groen, A.
    Staels, B.
    Luetjohann, D.
    Mulder, M.
    Vanmierlo, T.
    [J]. GLIA, 2019, 67 : E430 - E430
  • [7] Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease
    van Tijn, Paula
    Dennissen, Frank J. A.
    Gentier, Romina J. G.
    Hobo, Barbara
    Hermes, Denise
    Steinbusch, Harry W. M.
    Van Leeuwen, Fred W.
    Fischer, David F.
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2012, 61 (05) : 739 - 748
  • [8] Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease
    Sakakibara, Yasufumi
    Sekiya, Michiko
    Saito, Takashi
    Saido, Takaomi C.
    Iijima, Koichi M.
    [J]. BMC NEUROSCIENCE, 2019, 20
  • [9] Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer’s disease
    Yasufumi Sakakibara
    Michiko Sekiya
    Takashi Saito
    Takaomi C. Saido
    Koichi M. Iijima
    [J]. BMC Neuroscience, 20
  • [10] Vitamin C Restores Behavioral Deficits and Amyloid-β Oligomerization without Affecting Plaque Formation in a Mouse Model of Alzheimer's Disease
    Murakami, Kazuma
    Murata, Nakaba
    Ozawa, Yusuke
    Kinoshita, Noriaki
    Irie, Kazuhiro
    Shirasawa, Takuji
    Shimizu, Takahiko
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 (01) : 7 - 18